Sollievo Pharmaceuticals
Early Stage
When Minutes Matter
Overview
Raised: $40,715
Total Commitments ($USD)
Platform
StartEngine
Start Date
08/04/2022
Close Date
12/16/2022
Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment
$400
Security Type
Equity - Common
Series
Pre-Seed
SEC Filing Type
RegCF
Price Per Share
$2.00
Pre-Money Valuation
$20,000,000
Rolling Commitments ($USD)
Status
Funded
Reporting Date
12/30/2022
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$306
# of Investors
42
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2018
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Sollievo Pharmaceuticals, with a valuation of $20 million, is raising funds on StartEngine. The company has developed a fast-acting sedative in the form of an injectable benzodiazepine. The sedative, Proviza, causes rapid sedation in agitated and aggressive patients and protects healthcare staff from injuries and abuse. Proviza is highly water-soluble and brings about sedation in 5-10 minutes. Robert Schultz founded Sollievo Pharmaceuticals in February 2018. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for the completion of the patient clinical trial, submission of the New Drug Application, and receiving FDA approval.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-189,478 |
$-1,164,009 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$153 |
$1,157 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$153 |
$1,157 |
|
Short-Term Debt |
$772,225 |
$655,821 |
|
Long-Term Debt |
$1,252,890 |
$1,180,819 |
|
Total Liabilities |
$2,025,115 |
$1,836,640 |
Financials as of: 08/04/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.